Sotelo J, Torres B, Rubio-Donnadieu F, Escobedo F, Rodriguez-Carbajal J
Neurology. 1985 May;35(5):752-5. doi: 10.1212/wnl.35.5.752.
Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy. CT and CSF analysis showed that 91% of patients with parenchymal cysts improved, and 47% of patients with chronic arachnoiditis had remission. A single treatment with praziquantel for 2 weeks, administered in a daily dose of 50 mg/kg of body weight, was highly effective in parenchymal cysticercosis but less effective in meningeal cysticercosis. The benefits were sustained for at least 1 year.
35例活动性神经囊尾蚴病患者接受了吡喹酮治疗，并在治疗后随访1年。CT和脑脊液分析显示，91%的实质囊肿患者病情改善，47%的慢性蛛网膜炎患者病情缓解。吡喹酮单次治疗2周，每日剂量为50mg/kg体重，对实质型囊尾蚴病高度有效，但对脑膜型囊尾蚴病效果较差。疗效至少持续1年。
